Journal of Biology and Medicine: Open Access
Usage of Evidence-Based Plant Medicine in Multimorbidity Lymphadenopathy Conditions
Sengamalam Radhakrishnan and Ravindran Muthukumarasamy
Abstract
Immunoglobulin therapy is a popular trend and play a probability in assessing patient having defects such as Ig G diseases such as chronic lymphocytic leukemia, multiple myeloma, hypoimmune globulinaemia, and Ig M diseases such as hyperimmune globulinaemia, hepatitis, Ebola virus related with hemorrhagic fever, hepatitis B, Rabies, Tetanus toxin. This indispensable therapy helps to resolve various hypothetical disease conditions such as sepsis such as multiple sclerosis, neonatal sepsis, pediatric HIV/AIDS, PANDAS (pediatric autoimmune neuropsychiatric condition), a disorder associated with streptococcal cystic fibrosis), and unpredictable factor Chronic fatigue syndrome. This therapy involves maintaining a positive relationship with stress management with various factors such as innovation-based learning, Career concern, role ambiguity, rotating work shifts, role conflict, occupational demands, lack of participation in decision making, work overload, work under load, poor working conditions, lack of group cohesiveness, interpersonal and intergroup conflict, organizational changes and lack of social support. This article seeks to explicate and contextualize the empirical relationship between rigid chromophoric group plant constituents as well as shifting coincidence with various auxochromic groups which helps to reduce or increase or balancing about immunochemical reaction as well as management of lymphadenopathy conditions.
Keywords: IgM, IgG, Multimorbidity, Herbal medicines, Lymphadenopathy
Journal Information
- Journal Name: Journal of Biology and Medicine: Open Access
- Journal Abbreviation: J Bio Med Open Access
- Journal Code: JBMOA
- Format of Publication: Online
- Frequency of Publication: Two Issue a Year
- Language: English
- Starting Year: 2020
- Subject: Biology, Medicine, Medical Sciences
- Review Process: Single-Blind Peer-Review by Referees
- Time to 1st Decision: 1 to 4 weeks from date of submission
- Time to Acceptance: 3 to 6 weeks, depending upon the required revision cycles
- Time to Publication: 1 to 2 weeks from date of final submission
- Editor-in-Chief: CHEE KONG YAP
Indexed and Abstracted In
